We got cracking at our nation’s capital in the #ShockwaveIVL coronary imaging and calcium modification symposium at #CRT2025. Thank you to Drs. Jas Singh, Kevin Croce, Carlos Collet, Hector Tamez, and Evan Shlofmitz for leading the charge on discussing the latest in CCTA pre-PCI planning, the latest OCT catheter and highlighting our proven crack record. US Rx only. Important Safety Information: https://bit.ly/3iEq7fC
Shockwave Medical
医疗设备制造业
Santa Clara,California 96,739 位关注者
Making waves for underserved patients with cardiovascular disease via novel technologies. ???
关于我们
Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotripsy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. Stay connected with us at www.ShockwaveMedical.com and on Twitter @ShockwaveIVL
- 网站
-
https://shockwavemedical.com
Shockwave Medical的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 1,001-5,000 人
- 总部
- Santa Clara,California
- 类型
- 上市公司
地点
-
主要
5403 Betsy Ross Dr
US,California,Santa Clara,95054
Shockwave Medical员工
-
Lori Dossola Lyle
Marketing at Shockwave Medical, Inc.
-
Erika Johnson
-
Bharath Natarajan
Senior Director, Data Platform and Business Intelligence
-
Jason Shields
Medical Device Executive | General Management | Commercial Execution | Marketing | Professional Education | Business Development | Digital Surgery
动态
-
The ROLLING STONE trial is the largest prospective investigator-initiated multicenter registry comparing the safety and efficacy of #ShockwaveIVL and atherectomy. The >1000 patient study presented at #CRT2025 by Dr. Enrico Cerrato reiterates the safety of #CoronaryIVL. The results confirm lower MACE rates with IVL versus atherectomy at 1 year. US Rx only. Important Safety Information:?https://bit.ly/3iEq7fC #ROLLINGSTONEtrial
-
-
Attending #CRT2025? Explore the versatility of #PeripheralIVL in our symposium on Monday! See the latest data on our workhorse catheter #ShockwaveE8 and meet #ShockwaveJavelin, the new catheter specifically designed for calcified occlusive disease. US Rx only. Important Safety Information: https://bit.ly/3iEq7fC
-
-
This International Women’s Day, learn how the EMPOWER CAD study is addressing the underrepresentation of women in interventional cardiology trials, and enhancing the equity in treating plaque in women with CAD. Watch the #SCAI CME-accredited conversation with Drs Dean Kereiakes, Margaret McEntegart, Suzanne Baron & Robert Riley on #EMPOWERCAD. Watch the program and claim CME credit here: https://lnkd.in/gdJJeBBg US Rx only. Important Safety Information: https://bit.ly/3iEq7fC Caution: Shockwave Coronary Javelin is an Investigational Device. Limited by Federal (or United States) law to investigational use.
-
-
Dr. Alfonso Jurado-Román, MD, PhD's ROLLER COASTR-EPIC22 findings are now published in JACC Journals. Read more about this randomized trial comparing the safety and efficacy of #ShockwaveIVL, ELCA and RA for treatment of heavily calcified coronary lesions: https://lnkd.in/gHssjg9k US Rx only. Important Safety Information: https://bit.ly/3iEq7fC #RollerCoastrTrial
-
-
Keep your finger on the pulse of patient-focused innovation. Discover the latest #ShockwaveIVL device releases, clinical data, publications and more in our Q4 PulsePoint Newsletter: https://lnkd.in/gXUJX6K5 US Rx only. Important Safety Information: https://bit.ly/3iEq7fC
-
-
Congratulations to Drs. David Wood, Sophie Offen and Hassan Ogran and the team at Vancouver Coastal Health General Hospital in Vancouver, BC, Canada for joining the growing number of #COSIRAII enrolling sites and completing their 1st randomized patient for the trial. Want to learn more about the COSIRA-II trial and the participating sites? Visit https://clinicaltrials.gov ISI https://bit.ly/3iEq7fC Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability.
-
-
On Sunday at #CRT2025, Drs Jasvinder Singh, Kevin Croce, Carlos Collet, Hector Tamez & Evan Shlofmitz demonstrate the latest advances for treating calcified #CAD. Tune in to watch the physicians break down the safety and efficacy of #CoronaryIVL in real world scenarios. US Rx only. Important Safety Information: https://bit.ly/3iEq7fC #ShockwaveIVL
-
-
Last call! Sign up to attend our interactive #ShockwaveJavelin peripheral launch webinar at 8pm EST TODAY. If you’re a vascular surgeon, register now to learn about this first-of-its-kind Forward IVL platform and ask any questions you have. Register here: https://lnkd.in/gWfGpwqp US Rx only. Important Safety Information: https://bit.ly/3iEq7fC #LeadTheCharge #ShockwaveIVL #Vascular #OcclusiveDisease #PeripheralCalcium #PAD #MedEd
-
-
Different coronary calcium morphologies require different treatment approaches. Dr Robert Riley discusses how his algorithm shifts based on lesion type to facilitate the best possible patient outcomes. US Rx only. Important Safety Information: https://bit.ly/3iEq7fC #ShockwaveP2P #ShockwaveIVL